Novartis AGNYSE:NVS
Symbol Lookup
Refresh
Recent News»
1 New Today| Company | Market Cap | P/E Ratio (TTM) | EPS Growth (5yr) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer Inc PFE | 204.1B | 20.4x | +1.33% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GlaxoSmithKline PLC GSK | 130.9B | 20.7x | -0.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sanofi SA SNY | 145.9B | 22.8x | -0.79% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG RHHBY | 223.9B | 22.5x | -0.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Johnson & Johnson JNJ | 248.8B | 24.1x | +1.22% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Data delayed 15 minutes. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Information
Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. The Company has five segments: Pharmaceuticals, which include patent-protected prescription medicines; Alcon, which include surgical, ophthalmic pharmaceutical and vision care products; Sandoz, which include generic pharmaceuticals; vaccines and diagnostics, which include human vaccines and blood-testing diagnostics, and consumer health, which include over-the-counter medicines (OTC) and Animal Health. On April 8, 2011, the Company acquired the remaining non-controlling interest in Alcon, Inc.
| Headquarters | Lichtstrasse 35 BASEL, Switzerland 4056 |
|---|---|
| Phone | -- |
| Fax | -- |
EXECUTIVE OFFICERS
| Chairman of the Board of Directors | Daniel Vasella |
|---|---|
| Chief Executive Officer, Member of the Executive Committee | Joseph Jimenez |
| Vice Chairman of the Board of Directors, Non-Executive Director | Ulrich Lehner |
| Chief Financial Officer, Member of the Executive Committee | Jonathan Symonds |
| Group General Counsel, Member of the Executive Committee | Felix Ehrat |
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
Open a New Account, or Login if you're a client.
(GAAP)*
| Market Cap | $202.7B | Beta | 0.57 |
|---|---|---|---|
| Revenue (TTM) | $57.9B | EPS | $3.91 |
| Shares Out. | 2.7B | Book Value | $28.54 |
| Dividend Yield | 2.11% | P/E | 19.1x |
| Annual Dividend Rate | $1.58 | Price/Sales (TTM) | 3.5 |
| Ex-Div Date | 2/26/13 | P/Cash Flow (TTM) | 14.1x |
| Pay Date | 2/26/14 | Operating Margin | 20.04% |
*GAAP = prior to non-GAAP analyst adjusted earnings.
(Non-GAAP)*
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
